Article Text
Abstract
Objectives Electrocardiographic bundle branch block (BBB) is common but the prognostic implications in primary care are unclear. We sought to investigate the relationship between electrocardiographic BBB subtypes and the risk of cardiovascular (CV) outcomes in a primary care population free of major CV disease.
Methods Retrospective cohort study of primary care patients referred for electrocardiogram (ECG) recording between 2001 and 2011. Cox regression models were used to estimate hazard ratios (HR) as well as absolute risks of CV outcomes based on various BBB subtypes.
Results We included 202 268 individuals with a median follow-up period of 7.8 years (Inter-quartile range [IQR] 4.9–10.6). Left bundle branch block (LBBB) was associated with heart failure (HF) in both men (HR 3.96, 95% CI 3.30 to 4.76) and women (HR 2.51, 95% CI 2.15 to 2.94) and with CV death in men (HR 1.80, 95% CI 1.38 to 2.35). Right bundle branch block (RBBB) was associated with pacemaker implantation in both men (HR 3.26, 95% CI 2.74 to 3.89) and women (HR 3.69, 95% CI 2.91 to 4.67), HF in both sexes and weakly associated with CV death in men. Regarding LBBB, we found an increasing hazard of HF with increasing QRS-interval duration (HR 1.25, 95% CI 1.11 to 1.42 per 10 ms increase in men and HR 1.23, 95% CI 1.08 to 1.40 per 10 ms increase in women). Absolute 10-year risk predictions across age-specific and sex-specific subgroups revealed clinically relevant differences between having various BBB subtypes.
Conclusions Opportunistic findings of BBB subtypes in primary care patients without major CV disease should be considered warnings of future HF and pacemaker implantation.
- electrocardiography
- heart failure
- pacemakers
- cardiac risk factors and prevention
Statistics from Altmetric.com
Footnotes
PVR and MWS contributed equally.
Contributors Study concept and design were determined by: PVR, JBN, MWS, AGH. Acquisition of data was performed by: CG, AHP, JBN. Digital ECG analysis was performed by: PVR,JBN, CG, JM. Drafting of the manuscript was carried out by: PVR, MWS, JBN. Critical revision of the manuscript for important intellectual content was carried out by: JBN, MWS, JG, CG, AHP, MSO, SH, JHS, LK, JM, SH, CT-P, LK, AGH. Statistical analysis and data interpretation were performed by: PVR, MWS, JBN, JG. Fund raising was performed by: JBN, CG, SH, AGH.
Funding This study was supported by The Research Committee of Rigshospitalet and The John and Birthe Meyer Foundation. JBN was supported by the Danish Heart Foundation (16-R107-A6779), the Lundbeck Foundation (R220-2016-1434), the AP Møller Foundation for the Advancement of Medical Science and Fondsbørsvekselerer Henry Hansen og Hustru Karla Hansen Født Vestergaards Legat.
Competing interests AGH is an employee of Novo Nordisk A/S.
Ethics approval Due to no active participation from study subjects, no approval from an ethics committee was required according to Danish law. The use of register data was approved by the Danish Data Protection Agency.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement There are no unpublished data from the study.
Patient consent for publication Not required.